{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T23:59:08Z","timestamp":1762214348803,"version":"build-2065373602"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007034","name":"Thales Group","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007034","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.neuropharm.2019.107919","type":"journal-article","created":{"date-parts":[[2019,12,23]],"date-time":"2019-12-23T11:21:05Z","timestamp":1577100065000},"page":"107919","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Anti-neuroinflammatory, protective effects of the synthetic microneurotrophin BNN-20 in the advanced dopaminergic neurodegeneration of \u201cweaver\u201d mice"],"prefix":"10.1016","volume":"165","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8006-552X","authenticated-orcid":false,"given":"Vasiliki","family":"Panagiotakopoulou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Botsakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Foteini","family":"Delis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodora","family":"Mourtzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manolis N.","family":"Tzatzarakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aggeliki","family":"Dimopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nafsika","family":"Poulia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katerina","family":"Antoniou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios T.","family":"Stathopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos","family":"Matsokis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis","family":"Charalampopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Achilleas","family":"Gravanis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fevronia","family":"Angelatou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2019.107919_bib1","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/0140-6736(91)92989-F","article-title":"Parkinson's disease: pathophysiology","volume":"337","author":"Agid","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2019.107919_bib2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s13311-013-0218-1","article-title":"Pathogenesis-targeted, disease-modifying therapies in Parkinson disease","volume":"11","author":"AlDakheel","year":"2014","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neuropharm.2019.107919_bib3","article-title":"DHEA inhibits acute microglia-mediated inflammation through activation of the TrkA-Akt1\/2-CREB-Jmjd3 pathway","author":"Alexaki","year":"2017","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2019.107919_bib4","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.bbr.2007.10.010","article-title":"Individual responses to novelty are associated with differences in behavioral and neurochemical profiles","volume":"187","author":"Antoniou","year":"2008","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2019.107919_bib5","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/j.1582-4934.2011.01356.x","article-title":"Brain-derived neurotrophic factor induces proliferation of human airway smooth muscle cells","volume":"16","author":"Aravamudan","year":"2012","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.neuropharm.2019.107919_bib6","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s10787-017-0331-6","article-title":"Sitagliptin and liraglutide reversed nigrostriatal degeneration of rodent brain in rotenone-induced Parkinson's disease","volume":"25","author":"Badawi","year":"2017","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.neuropharm.2019.107919_bib7","doi-asserted-by":"crossref","first-page":"6251","DOI":"10.1523\/JNEUROSCI.4601-04.2005","article-title":"Brain-Derived neurotrophic factor is required for the establishment of the proper number of dopaminergic neurons in the substantia nigra pars compacta","volume":"25","author":"Baquet","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.107919_bib8","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3389\/fncel.2014.00254","article-title":"BDNF signaling and survival of striatal neurons","volume":"8","author":"Baydyuk","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.107919_bib9","first-page":"9137","article-title":"Selective vulnerability of late-generated dopaminergic neurons of the substantia nigra in weaver mutant mice","volume":"92","author":"Bayer","year":"1995","journal-title":"Neurobiology"},{"key":"10.1016\/j.neuropharm.2019.107919_bib10","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1016\/j.neurobiolaging.2005.09.028","article-title":"DHEA improves symptomatic treatment of moderately and severely impaired MPTP monkeys","volume":"27","author":"B\u00e9langer","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2019.107919_bib11","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.bcp.2016.08.001","article-title":"Pharmacological properties of microneurotrophin drugs developed for treatment of amyotrophic lateral sclerosis","volume":"117","author":"Bennett","year":"2016","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.107919_bib12","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrn2038","article-title":"Microglia-mediated neurotoxicity: uncovering the molecular mechanisms","volume":"8","author":"Block","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.107919_bib13","article-title":"Review\u00a0: activation patterns of microglia and their identification in the human brain","volume":"3\u201318","author":"Boche","year":"2013","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.neuropharm.2019.107919_bib14","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1002\/glia.23170","article-title":"The novel synthetic microneurotrophin BNN27 protects mature oligodendrocytes against cuprizone-induced death, through the NGF receptor TrkA","volume":"65","author":"Bonetto","year":"2017","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2019.107919_bib15","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.neuropharm.2017.04.043","article-title":"BNN-20, a synthetic microneurotrophin, strongly protects dopaminergic neurons in the \u201cweaver\u201d mouse, a genetic model of dopamine-denervation, acting through the TrkB neurotrophin receptor","volume":"121","author":"Botsakis","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2019.107919_bib16","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1159\/000438789","article-title":"Neuroprotective effect of progesterone in MPTP-treated male mice","volume":"103","author":"Bourque","year":"2016","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.neuropharm.2019.107919_bib17","article-title":"Repurposing sex steroids and related drugs as potential treatment for Parkinson's disease","author":"Bourque","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2019.107919_bib18","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12974-016-0588-5","article-title":"Inflammatory profile in LRRK2-associated prodromal and clinical PD","volume":"13","author":"Brockmann","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuropharm.2019.107919_bib19","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/nri1668","article-title":"Regulation of immune responses by L-arginine metabolism","volume":"5","author":"Bronte","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.neuropharm.2019.107919_bib20","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1042\/BST0351119","article-title":"Mechanisms of inflammatory neurodegeneration: iNOS and NADPH oxidase","volume":"35","author":"Brown","year":"2007","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.neuropharm.2019.107919_bib21","doi-asserted-by":"crossref","first-page":"6569","DOI":"10.1021\/jm900468p","article-title":"Novel dehydroepiandrosterone derivatives with antiapoptotic, neuroprotective activity","volume":"52","author":"Calogeropoulou","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2019.107919_bib22","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.tem.2008.07.004","article-title":"Neurosteroids as modulators of neurogenesis and neuronal survival","volume":"19","author":"Charalampopoulos","year":"2008","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.neuropharm.2019.107919_bib23","doi-asserted-by":"crossref","first-page":"8209","DOI":"10.1073\/pnas.0306631101","article-title":"Dehydroepiandrosterone and allopregnanolone protect sympathoadrenal medulla cells against apoptosis via antiapoptotic Bcl-2 proteins","volume":"101","author":"Charalampopoulos","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.neuropharm.2019.107919_bib24","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/sj.mp.4001893","article-title":"Valproate protects dopaminergic neurons in midbrain neuron\/glia cultures by stimulating the release of neurotrophic factors from astrocytes","volume":"11","author":"Chen","year":"2006","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2019.107919_bib25","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/ana.21995","article-title":"Clinical progression in Parkinson disease and the neurobiology of axons","volume":"67","author":"Cheng","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2019.107919_bib26","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1016\/j.neuropharm.2012.01.028","article-title":"Contributions of central and systemic inflammation to the pathophysiology of Parkinson's disease","volume":"62","author":"Collins","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2019.107919_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/frne.1999.0188","article-title":"Neurosteroids: biosynthesis and function of these novel neuromodulators","volume":"21","author":"Compagnone","year":"2000","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.neuropharm.2019.107919_bib28","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1001\/jama.2014.3654","article-title":"Pharmacological treatment of Parkinson disease","volume":"311","author":"Connolly","year":"2014","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.neuropharm.2019.107919_bib29","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/syn.10145","article-title":"Dehydroepiandrosterone (DHEA) such as 17beta-estradiol prevents MPTP-induced dopamine depletion in mice","volume":"47","author":"D'Astous","year":"2003","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2019.107919_bib30","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/syn.10145","article-title":"Dehydroepiandrosterone (DHEA) such as 17\u03b2-estradiol prevents MPTP-induced dopamine depletion in mice","volume":"47","author":"D'Astous","year":"2003","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2019.107919_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002015","article-title":"PARK2 mediates interleukin 6 and monocyte chemoattractant protein 1 production by human macrophages","volume":"7","author":"de L\u00e9s\u00e9leuc","year":"2013","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.neuropharm.2019.107919_bib32","first-page":"S21","article-title":"Prevalence of Parkinson\u2019s disease in europe: a collaborative study of population-based cohorts. Neurologic diseases in the elderly research group","volume":"54","author":"de Rijk","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2019.107919_bib33","doi-asserted-by":"crossref","first-page":"4259","DOI":"10.1007\/s00018-013-1352-y","article-title":"The role of inflammation in sporadic and familial Parkinson's disease","volume":"70","author":"Deleidi","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.neuropharm.2019.107919_bib34","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.physbeh.2007.07.015","article-title":"Weaver mutant mice exhibit long-term learning deficits under several measures of instrumental behavior","volume":"92","author":"Derenne","year":"2007","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2019.107919_bib35","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.molbrainres.2004.09.011","article-title":"Metallothionein-mediated neuroprotection in genetically engineered mouse models of Parkinson's disease","volume":"134","author":"Ebadi","year":"2005","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.neuropharm.2019.107919_bib36","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/nrneurol.2016.196","article-title":"Precision medicine for disease modification in Parkinson disease","volume":"13","author":"Espay","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neuropharm.2019.107919_bib37","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/sj.tpj.6500360","article-title":"Shedding light into the role of BDNF in the pharmacotherapy of Parkinson's disease","volume":"6","author":"Fumagalli","year":"2006","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.neuropharm.2019.107919_bib38","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0197-0186(92)90257-R","article-title":"Degeneration of mesencephalic dopamine neurons in weaver mutant mice","volume":"20","author":"Ghetti","year":"1992","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2019.107919_bib40","first-page":"783","article-title":"Changing face of microglia","volume":"330","author":"Graeber","year":"2010","journal-title":"Science 80"},{"key":"10.1016\/j.neuropharm.2019.107919_bib41","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00401-009-0622-0","article-title":"Microglia: biology and pathology","volume":"119","author":"Graeber","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuropharm.2019.107919_bib43","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.14667","article-title":"Synthetic microneurotrophins in therapeutics of neurodegeneration","volume":"8","author":"Gravanis","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.neuropharm.2019.107919_bib45","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.brainresrev.2009.11.004","article-title":"Neuroglia in neurodegeneration","volume":"63","author":"Heneka","year":"2009","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.neuropharm.2019.107919_bib46","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1006\/exnr.2000.7483","article-title":"Reduced BDNF mRNA expression in the Parkinson's disease substantia nigra","volume":"166","author":"Howells","year":"2000","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2019.107919_bib48","doi-asserted-by":"crossref","DOI":"10.1177\/0300060517748843","article-title":"Serum concentration and clinical significance of brain-derived neurotrophic factor in patients with Parkinson's disease or essential tremor","volume":"46","author":"Huang","year":"2018","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.neuropharm.2019.107919_bib49","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/350230a0","article-title":"BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra","volume":"350","author":"Hyman","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2019.107919_bib50","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2337\/db17-0391","article-title":"The synthetic microneurotrophin BNN27 affects retinal function in rats with streptozotocin-induced diabetes","volume":"67","author":"Ib\u00e1n-Arias","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.neuropharm.2019.107919_bib52","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1111\/j.1460-9568.2009.06898.x","article-title":"NF-\u03baB-dependent regulation of brain-derived neurotrophic factor in hippocampal neurons by X-linked inhibitor of apoptosis protein","volume":"30","author":"Kairisalo","year":"2009","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.107919_bib53","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1002\/mds.26354","article-title":"Disease-modifying strategies for Parkinson's disease","volume":"30","author":"Kalia","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuropharm.2019.107919_bib54","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1152\/physrev.00011.2010","article-title":"Physiology of microglia","volume":"91","author":"Kettenmann","year":"2011","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2019.107919_bib55","doi-asserted-by":"crossref","first-page":"a008888","DOI":"10.1101\/cshperspect.a008888","article-title":"Genetics of Parkinson's disease","volume":"2","author":"Klein","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.neuropharm.2019.107919_bib56","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1086\/315877","article-title":"Pharmacologic interference with NF\u2010\u03baB activation attenuates central nervous system complications in experimental pneumococcal meningitis","volume":"182","author":"Koedel","year":"2000","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.neuropharm.2019.107919_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1001051","article-title":"Neurosteroid dehydroepiandrosterone interacts with nerve growth factor (NGF) receptors, preventing neuronal apoptosis","volume":"9","author":"Lazaridis","year":"2011","journal-title":"PLoS Biol."},{"key":"10.1016\/j.neuropharm.2019.107919_bib58","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrn3505","article-title":"BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases","volume":"14","author":"Lu","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.107919_bib59","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.chroma.2008.07.057","article-title":"Routine method for the simultaneous quantification of 17\u03b1-hydroxyprogesterone, testosterone, dehydroepiandrosterone, androstenedione, cortisol, and pregnenolone in human serum of neonates using gas chromatography\u2013mass spectrometry","volume":"1206","author":"Magnisali","year":"2008","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.neuropharm.2019.107919_bib60","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.yfrne.2008.11.002","article-title":"Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS)","volume":"30","author":"Maninger","year":"2009","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.neuropharm.2019.107919_bib61","first-page":"121","article-title":"Role of brain-derived neurotrophic factor and NF-\u03baB in neuronal plasticity and survival: from genes to phenotype","volume":"22","author":"Marini","year":"2004","journal-title":"Restor. Neurol. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.107919_bib62","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/sj.cdd.4401837","article-title":"Roles for NF-\u03baB in nerve cell survival, plasticity, and disease","volume":"13","author":"Mattson","year":"2006","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.neuropharm.2019.107919_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/S0304-3940(99)00463-2","article-title":"Brain-derived growth factor and nerve growth factor concentrations are decreased in the substantia nigra in Parkinson's disease","author":"Mogi","year":"1999","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2019.107919_bib64","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ijdevneu.2009.06.005","article-title":"Altered levels of synapsin I, dopamine transporter, dynorphin A, and neuropeptide Y in the nucleus accumbens and striatum at post-puberty in rats treated neonatally with pregnenolone or DHEA","volume":"27","author":"Muneoka","year":"2009","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.107919_bib65","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nrd3366","article-title":"Potential therapeutic uses of BDNF in neurological and psychiatric disorders","volume":"10","author":"Nagahara","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2019.107919_bib67","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/00001756-199902250-00021","article-title":"Reduced expression of brain-derived neurotrophic factor protein in Parkinson's disease substantia nigra","volume":"10","author":"Parain","year":"1999","journal-title":"Neuroreport"},{"year":"2013","author":"Paxinos","key":"10.1016\/j.neuropharm.2019.107919_bib68"},{"key":"10.1016\/j.neuropharm.2019.107919_bib69","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1210\/en.2014-1596","article-title":"Dehydroepiandrosterone: an ancestral ligand of neurotrophin receptors","volume":"156","author":"Pediaditakis","year":"2015","journal-title":"Endocrinology"},{"key":"10.1016\/j.neuropharm.2019.107919_bib70","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.3447-06.2006","article-title":"Nigrostriatal dopaminergic neurodegeneration in the weaver mouse is mediated via neuroinflammation and alleviated by minocycline administration","volume":"26","author":"Peng","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.107919_bib71","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/j.pnpbp.2008.06.002","article-title":"Acute dehydroepiandrosterone treatment exerts different effects on dopamine and serotonin turnover ratios in the rat corpus striatum and nucleus accumbens","volume":"32","author":"P\u00e9rez-Neri","year":"2008","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2019.107919_bib72","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrneurol.2010.17","article-title":"Microglia in neurodegenerative disease","volume":"6","author":"Perry","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neuropharm.2019.107919_bib73","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1089\/ars.2006.8.478","article-title":"NF-\u03baB: a stress-regulated switch for cell survival","volume":"8","author":"Piva","year":"2006","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.neuropharm.2019.107919_bib74","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1017\/S1461145709991003","article-title":"Individual differences in the effects of cannabinoids on motor activity, dopaminergic activity and DARPP-32 phosphorylation in distinct regions of the brain","volume":"13","author":"Polissidis","year":"2010","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2019.107919_bib75","doi-asserted-by":"crossref","DOI":"10.1038\/nrn3722","article-title":"Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease","author":"Prinz","year":"2014","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.107919_bib76","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/nn.4338","article-title":"A polarizing question: do M1 and M2 microglia exist?","volume":"19","author":"Ransohoff","year":"2016","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.107919_bib77","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1023\/A:1022545026007","article-title":"Distribution of dopamine, its metabolites, and D1 and D2 receptors in heterozygous and homozygous weaver mutant mice","volume":"24","author":"Reader","year":"1999","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2019.107919_bib78","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.neulet.2010.04.054","article-title":"Long-term consequences of early maternal deprivation in serotonergic activity and HPA function in adult rat","volume":"480","author":"Rentesi","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2019.107919_bib79","doi-asserted-by":"crossref","DOI":"10.1007\/s11481-006-9020-8","article-title":"Up-regulation of BDNF in astrocytes by TNF-\u03b1: a case for the neuroprotective role of cytokine","volume":"1","author":"Saha","year":"2006","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.107919_bib80","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.neuint.2011.10.018","article-title":"Exposure to novel environment is characterized by an interaction of D1\/NMDA receptors underlined by phosphorylation of the NMDA and AMPA receptor subunits and activation of ERK1\/2 signaling, leading to epigenetic changes and gene expression in rat hippoca","volume":"60","author":"Sarantis","year":"2012","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2019.107919_bib82","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1523\/JNEUROSCI.02-03-00376.1982","article-title":"Dopamine deficiency in the weaver mutant mouse","volume":"2","author":"Schmidt","year":"1982","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.107919_bib83","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF02816118","article-title":"The weaver mutant mouse as a model of nigrostriatal dysfunction","volume":"9","author":"Simon","year":"1994","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2019.107919_bib84","doi-asserted-by":"crossref","first-page":"18514","DOI":"10.1073\/pnas.0705316104","article-title":"Epithelial NF-\u03baB activation promotes urethane-induced lung carcinogenesis","volume":"104","author":"Stathopoulos","year":"2007","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2019.107919_bib85","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s12035-014-9070-5","article-title":"Differential roles of M1 and M2 microglia in neurodegenerative diseases","volume":"53","author":"Tang","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2019.107919_bib86","doi-asserted-by":"crossref","first-page":"709","DOI":"10.2741\/2713","article-title":"Neuroinflammation in Parkinson's disease: is there sufficient evidence for mechanism-based interventional therapy?","volume":"13","author":"Tansey","year":"2008","journal-title":"Front. Biosci."},{"key":"10.1016\/j.neuropharm.2019.107919_bib88","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/BF00248351","article-title":"Mesencephalic dopamine cell deficit involves areas A8, A9 and A10 in weaver mutant mice","volume":"70","author":"Triarhou","year":"1988","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.neuropharm.2019.107919_bib89","doi-asserted-by":"crossref","first-page":"22544","DOI":"10.1038\/srep22544","article-title":"Microglial activation induces neuronal death in Chandipura virus infection","volume":"6","author":"Verma","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2019.107919_bib90","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0166-2236(98)01362-9","article-title":"Stereological methods for estimating the total number of neurons and synapses: issues of precision and bias","volume":"22","author":"West","year":"1999","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2019.107919_bib91","first-page":"335","article-title":"Endogenous neuroprotective factors: neurosteroids","volume":"58","author":"Wojtal","year":"2006","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.neuropharm.2019.107919_bib93","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0006-8993(02)03666-1","article-title":"Involvement of a spinal brain-derived neurotrophic factor\/full-length TrkB pathway in the development of nerve injury-induced thermal hyperalgesia in mice","volume":"958","author":"Yajima","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2019.107919_bib94","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1046\/j.1471-4159.2001.00497.x","article-title":"Differences in survival-promoting effects and intracellular signaling properties of BDNF and IGF-1 in cultured cerebral cortical neurons","volume":"78","author":"Yamada","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2019.107919_bib95","doi-asserted-by":"crossref","first-page":"4394","DOI":"10.1158\/0008-5472.CAN-04-0343","article-title":"Akt\/protein kinase B signaling inhibitor-2, a selective small molecule inhibitor of Akt signaling with antitumor activity in cancer cells overexpressing Akt","volume":"64","author":"Yang","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.neuropharm.2019.107919_bib96","doi-asserted-by":"crossref","first-page":"10252","DOI":"10.1038\/srep10252","article-title":"Transient blockade of ERK phosphorylation in the critical period causes autistic phenotypes as an adult in mice","volume":"5","author":"Yufune","year":"2015","journal-title":"Sci. Rep."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390819304903?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390819304903?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T23:55:34Z","timestamp":1762214134000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390819304903"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":87,"alternative-id":["S0028390819304903"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2019.107919","relation":{},"ISSN":["0028-3908"],"issn-type":[{"type":"print","value":"0028-3908"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-neuroinflammatory, protective effects of the synthetic microneurotrophin BNN-20 in the advanced dopaminergic neurodegeneration of \u201cweaver\u201d mice","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2019.107919","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107919"}}